Triple
T17046855
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Epclusa |
E413592
|
entity |
| Predicate | containsDoseOfSofosbuvir |
P125639
|
FINISHED |
| Object | 400 mg |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: 400 mg | Statement: [Epclusa, containsDoseOfSofosbuvir, 400 mg]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: containsDoseOfSofosbuvir Context triple: [Epclusa, containsDoseOfSofosbuvir, 400 mg]
-
A.
hasInitialDose
Indicates that an entity has received or is assigned a first or starting dose of a treatment, medication, or substance.
-
B.
isIndicatedAsMonotherapyFor
Indicates that a treatment is recommended or used alone, without combination with other therapies, for a particular condition or purpose.
-
C.
hasDefinedDailyDose
Indicates that an entity has an established standard amount intended to be taken or used per day.
-
D.
hasHigherDoseStrength
Indicates that one entity has a greater dose strength than another entity in a comparative relationship.
-
E.
hasBiosimilar
Indicates that one biological product is a biosimilar counterpart to another reference biological product.
- F. None of above. chosen
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d886cd18288190b006abab23f811b7 |
completed | April 10, 2026, 5:12 a.m. |
| NER | Named-entity recognition | batch_69e3da9e3d8881909f197aba0e4c97e7 |
completed | April 18, 2026, 7:25 p.m. |
| PD | Predicate disambiguation | batch_69e35d60a588819084f53ef9f8b2e7c0 |
completed | April 18, 2026, 10:30 a.m. |
| PDg | Predicate description generation | batch_69e3753f93c88190808fec5692f66699 |
completed | April 18, 2026, 12:12 p.m. |
Created at: April 10, 2026, 5:34 a.m.